Little Green announces an AU$5.0 million placement

Mar 24, 2023

Little Green Pharma Ltd (ASX: LGP) stated that it had received strong commitments from new and current institutional and sophisticated investors for an AU$5 million placement. Under the terms of the placement, the company will issue new fully paid ordinary shares at a price of AU$0.18 per share.

The placement offer price is 5.3% lower than the latest price closing on 21 March 2023 (AU$0.19 per share). The funds from the placement will be used to repay the remainder of the Canopy Loan Note, as well as for working capital and offer costs.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com